心脏衰老:分子机制和治疗干预措施
Xin Li1, Xiaoyan Pang2, Haiyan Sun3
1Department of Infectious Disease, The First Hospital of China Medical University, Shenyang, Liaoning 110001, PR China.
Pharmacological research
|September 18, 2025
概括
了解心脏衰老机制是预防心血管疾病 (CVD) 的关键. 针对相互连接的途径的系统级方法为促进心脏健康和寿命提供了新的希望.
科学领域:
- 心脏病学 心脏病学
- 老年学是一门学科.
- 分子生物学分子生物学
背景情况:
- 心脏衰老是心血管疾病 (CVD) 的主要危险因素,是全球主要的死亡原因.
- 关键的与年龄有关的心脏变化包括左心室缩,腹功能障碍和纤维化.
- 分子驱动因素包括自功能障碍,氧化应激,端粒缩短和表观遗传变化.
研究的目的:
- 审查驱动心脏衰老的机制.
- 评估治疗策略,以抵消心脏衰老.
- 倡导系统层面的方法来促进心血管健康.
主要方法:
- 文献综述综合了关于心脏衰老机制的当前研究.
- 分析老化心脏中的结构和功能变化.
- 探索涉及心脏衰老的分子通路.
- 评估各种干预措施,从改变生活方式到新疗法.
主要成果:
- 在衰老的心脏和核心分子通路 (自,线粒体,端粒体,表观遗传学) 中发现了标志性变化.
- 强调了像miR-34a这样的非编码RNA在心脏衰老中的作用.
- 评估的干预措施包括热量限制,拉巴胺素,老化剂,微生物组调制和基因编辑.
结论:
- 针对相互关联的衰老途径是心脏病学中的新疆.
- 需要转向协同作用的,系统级干预措施.
- 这些方法有可能将心血管健康延伸到疾病管理之外.
相关概念视频
Aging
612
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
612
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
942
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
942
Cardiomyopathy V: Interprofessional Care
339
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
339
Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
197
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
197


